Company Description
Saratoga Investment Corp. is a business development company specializing in leveraged and management buyouts, acquisition financings, growth financings, recapitalization, debt refinancing, and transitional financing transactions at the lower end of middle market companies.
It structures its investments as debt and equity by investing through first and second lien loans, mezzanine debt, co-investments, select high yield bonds, senior secured bonds, unsecured bonds, and preferred and common equity.
The firm prefers to invest in aerospace, automotive aftermarket and services, business products and services, consumer products and services, education, environmental services, industrial services, financial services, food and beverage, healthcare products and services, logistics, distribution, manufacturing, restaurants services, food services, software services, technology services, specialty chemical, media and telecommunications.
It seeks to invest in the United States. The firm primarily invests $5 million to $50 million in companies having EBITDA of $2 million or greater and revenues of $8 million to $250 million.
The firm prefer to take a majority stake. It invests through direct lending as well as participation in loan syndicates.
The firm was formerly known as GSC Investment Corp. Saratoga Investment Corp. was formed on 2007 and is based in New York, New York with an additional office in Florham Park, New Jersey.
| Country | United States |
| IPO Date | Mar 23, 2007 |
| Industry | Asset Management |
| Sector | Financials |
| CEO | Christian L. Oberbeck |
Contact Details
Address: 535 Madison Avenue New York, New York 10022 United States | |
| Phone | 212 750-3343 |
| Website | saratogainvestmentcorp.com |
Stock Details
| Ticker Symbol | SAR |
| Exchange | NYSE |
| Fiscal Year | March - February |
| Reporting Currency | USD |
| CIK Code | 0001377936 |
| CUSIP Number | 80349A208 |
| ISIN Number | US80349A2087 |
| Employer ID | 20-4876925 |
Key Executives
| Name | Position |
|---|---|
| Christian L. Oberbeck | Chairman, Chief Executive Officer and President |
| Henri J. Steenkamp | Chief Compliance Officer, Secretary, Treasurer, Chief Financial Officer and Director |
| Michael Joseph Grisius | Co-Managing Partner and Chief Investment Officer |
| Adam Prior | Senior Vice President |
| Richard A. Petrocelli CPA | Managing Director |
| Paul B. West | Managing Director |
| Marissa Mann Andrews | Principal |
| Thomas V. Inglesby J.D. | MD and Portfolio Manager |
| John F. MacMurray | MD and Portfolio Manager |
| Charles G. Phillips IV | Managing Director and Portfolio Manager |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 28, 2024 | 8-K | Current Report |
| Mar 12, 2024 | 40-17G | Filing |
| Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jan 9, 2024 | 8-K | Current Report |
| Jan 9, 2024 | 10-Q | Quarterly Report |
| Oct 10, 2023 | 10-Q | Quarterly Report |
| Oct 10, 2023 | 8-K | Current Report |
| Sep 28, 2023 | 8-K | Current Report |
| Sep 1, 2023 | 40-APP/A | Filing |
| Aug 7, 2023 | DEF 14A | Other definitive proxy statements |